# Guangzhou Perception Vision Medical Technologies Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/guangzhou-perception-vision-medical-technologies-co

- Industry: Healthcare IT
- Headquarters: Guangzhou, China
- Website: www.pvmedtech.com
- Total disclosed funding: $42M
- Latest round: Series B (Feb 1, 2024)
- Investors on record: 9

## About

Based in Guangzhou, China and founded in 2017, Guangzhou Perception Vision Medical Technologies Co., Ltd., dba PVmed, is a medical company that focuses on the field of artificial intelligence-assisted diagnosis and treatment. It has acquired more than 50 invention patents and more than 20 copyrights. The company has cooperations with Philips, National Cancer Centre Singapore, and other institutions. In 2019, it was recognized as a high-tech enterprise in Guangdong Province and was selected as one of the TOP 50 medical artificial intelligence companies of the year, as well as a series of other awards. The founder of the company, Prof. Lu Yao, has a double Ph.D. from the Chinese Academy of Sciences and Syracuse University and was a researcher at the University of Michigan Medical School. In February 2026, Guangzhou Perception Vision Medical Technologies Co., Ltd. closed a venture funding from Guangzhou Cherami Sun Tour Equity Investment Management.
 
The company is committed to providing integrated solutions for artificial intelligence-assisted diagnosis and treatment, such as the overall solution of intelligent radiotherapy, the overall solution of intelligent imaging, and the overall solution of intelligent surgery, which adopts computer vision, web imaging, and other technologies. The product of the company includes a page view(PV)-iCurve radiotherapy intelligent delineation system and a pv-idose dose intelligent analysis system.

## Funding rounds

- Series B, Feb 1, 2024, $13M — Cherami Investment Group
- Series A, Dec 22, 2022, $14M — Strategy Capital, JHF Investment, Coco Capital, Philips, Cherami Investment Group
- Series A, Aug 24, 2022 — JHF Investment
- Series A, Aug 20, 2021, $15M — Cherami Investment Group
- Series B, Jul 5, 2019 — Coco Capital
- Series A, May 24, 2018 — China Growth Capital, Cher Ami Wealth & Financial, Shenzhen Guozhong Venture Capital, Sunbow Capital
- Angel, Aug 29, 2017 — China Growth Capital

## Investors

- China Growth Capital (https://capitalatlas.ai/funds/china-growth-capital) — Angel, Series A
- Cher Ami Wealth & Financial — Series A
- Shenzhen Guozhong Venture Capital (https://capitalatlas.ai/funds/shenzhen-guozhong-venture-capital) — Series A
- Sunbow Capital (https://capitalatlas.ai/funds/sunbow-capital) — Series A
- Coco Capital (https://capitalatlas.ai/funds/coco-capital) — Series B, Series A
- Cherami Investment Group (https://capitalatlas.ai/funds/cherami-investment-group) — Series A, Series B
- JHF Investment (https://capitalatlas.ai/funds/jhf-investment) — Series A
- Strategy Capital — Series A
- Philips — Series A